Healthcare provider profile · identity verified

Marshall Wickens, DO

Family Practice · REED CITY, MI · NPI 1841263134

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	534	144
Atorvastatin Calcium	Atorvastatin Calcium	496	130
Lisinopril	Lisinopril	334	94
Omeprazole	Omeprazole	324	83
Tramadol Hcl	Tramadol Hcl	242	41
Levothyroxine Sodium	Levothyroxine Sodium	232	62
Metoprolol Succinate	Metoprolol Succinate	227	65
Losartan Potassium	Losartan Potassium	213	58
Furosemide	Furosemide	186	61
Potassium Chloride	Potassium Chloride	165	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	160	24
Metformin Hcl Er	Metformin Hcl	158	49
Tamsulosin Hcl	Tamsulosin Hcl	143	45
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	137	34
Gabapentin	Gabapentin	136	38
Metformin Hcl	Metformin Hcl	130	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	127	38
Hydrochlorothiazide	Hydrochlorothiazide	126	35
Eliquis	Apixaban	125	31
Metoprolol Tartrate	Metoprolol Tartrate	117	36
Simvastatin	Simvastatin	113	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	106	34
Allopurinol	Allopurinol	103	28
Azithromycin	Azithromycin	99	65
Glipizide Er	Glipizide	97	30
Prednisone	Prednisone	95	36
Trazodone Hcl	Trazodone Hcl	95	26
Rosuvastatin Calcium	Rosuvastatin Calcium	93	29
Pantoprazole Sodium	Pantoprazole Sodium	87	23
Sertraline Hcl	Sertraline Hcl	86	26
Pravastatin Sodium	Pravastatin Sodium	85	23
Fluticasone Propionate	Fluticasone Propionate	84	35
Escitalopram Oxalate	Escitalopram Oxalate	82	25
Duloxetine Hcl	Duloxetine Hcl	81	24
Spironolactone	Spironolactone	79	21
Albuterol Sulfate Hfa	Albuterol Sulfate	74	32
Carvedilol	Carvedilol	74	22
Mounjaro	Tirzepatide	73	19
Clopidogrel	Clopidogrel Bisulfate	65	19
Januvia	Sitagliptin Phosphate	63	18
Methylprednisolone	Methylprednisolone	63	52
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	16
Pioglitazone Hcl	Pioglitazone Hcl	60	21
Xarelto	Rivaroxaban	59	suppressed
Benazepril Hcl	Benazepril Hcl	58	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	18
Ozempic	Semaglutide	55	12
Lovastatin	Lovastatin	54	16
Pregabalin	Pregabalin	52	suppressed
Citalopram Hbr	Citalopram Hydrobromide	51	suppressed
Jardiance	Empagliflozin	51	12
Ramipril	Ramipril	49	12
Clonidine Hcl	Clonidine Hcl	48	11
Warfarin Sodium	Warfarin Sodium	48	12
Atenolol	Atenolol	47	13
Famotidine	Famotidine	47	13
Montelukast Sodium	Montelukast Sodium	46	12
Novolog Flexpen	Insulin Aspart	45	12
Bumetanide	Bumetanide	44	14
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Enalapril Maleate	Enalapril Maleate	40	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	12
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Cephalexin	Cephalexin	35	29
Trulicity	Dulaglutide	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Amoxicillin	Amoxicillin	33	27
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Farxiga	Dapagliflozin Propanediol	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Finasteride	Finasteride	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Myrbetriq	Mirabegron	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Morphine Sulfate	Morphine Sulfate	17	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Topiramate	Topiramate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Testosterone	Testosterone	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Primidone	Primidone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error